Drug intelligence / Profile preview

N-[[3-fluoro-4-ethoxy-pyrid-2-yl]ethyl]-N'-[5-chloro-pyridyl]-thiourea

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule featuring a thiourea backbone linked to two substituted pyridine rings—one with fluoro and ethoxy groups, the other with a chloro group. It is classified as an experimental molecule and has not been approved for clinical use. The compound has been studied structurally (PDB ligand code: FTC), but there are no published indications, clinical trials, or known therapeutic uses. Some structural studies have associated it with research on HIV proteins, suggesting possible utility as an antiviral probe or inhibitor in preclinical settings; however, no mechanism of action or biological target has been definitively established[1][6][8][10].

Other names
1-(5-chloropyridin-2-yl)-3-[2-(4-ethoxy-3-fluoropyridin-2-yl)ethyl]thiourea1-(5-Chloropyridin-2-yl)-3-(2-(4-ethoxy-3-fluoropyridin-2 yl)ethyl)thioureaN‑((3‑fluoro‑4‑ethoxy‑pyrid‑2‑yl)ethyl)–N'–(5–chloro–pyridyl)–thiourea

Beyond the preview

Go deeper on N-[[3-fluoro-4-ethoxy-pyrid-2-yl]ethyl]-N'-[5-chloro-pyridyl]-thiourea.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-[[3-fluoro-4-ethoxy-pyrid-2-yl]ethyl]-N'-[5-chloro-pyridyl]-thiourea.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call